Home > Tumor Markers: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers (Table of Contents)

Tumor Markers: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

Venture Planning Group
June 1, 2011
1200 Pages - SKU: VPG6417975

Abstract Table of Contents Related Reports

Introduction
Worldwide Market and Technology Overview: A. Cancer Statistics and Etiology; B. Major Current And Emerging Tumor Marker; C. Instrumentation Review And Market Needs; D. Current and Emerging Technologies; E. Competing/Complementing Technologies; F. Business Environment; G. Personal Testing
France: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth and Major Suppliers
Germany: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth and Major Suppliers
Italy: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth and Major Suppliers
Japan: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth and Major Suppliers
Spain: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth and Major Suppliers
U.K.: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth and Major Suppliers
U.S.A.: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth and Major Suppliers Sales, Instrument Placements and Market Shares
Major Product Development Opportunities: A. Reagent Kits and Test Systems/Panels; B. Instrumentation; C. Computers, Software and Automation; D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies: A. Internal Development; B. Collaborative Arrangements; C. University Contracts; D. Distribution Strategies
Potential Market Entry Barriers and Risks: A. Market Maturity; B. Cost Containment; C. Competition; D. Technological Edge and Limitations; E. Patent Protection; F. Regulatory Constraints; G. Decentralized Testing Market Challenges
Competitive Profiles: Abbott; AdnaGen; Ambrilia Biopharma; AMDL; Beckman Coulter; Becton Dickinson; Biomedical Diagnostics; bioMerieux; Bio-Rad; CanAG Diagnostics; CeMines; Cepheid; Correlogic Systems; Dako; Decode; Diadexus; Diagnocure; Diasorin; Eiken Chemical; Enterix; Enzo Biochem; Epigenomics; Exact Sciences; Fujirebio; Gen-Probe; Guided Therapeutics; Hologic; Ipsogen; J&J Diagnostics; Kreatech; Kyowa Medex; Mackay Life Sciences; Matritech; Myriad Genetics; OncoLab; Panacea Pharmaceuticals; Polartechnics; Polymedco; PreMD; Qiagen; Radient Pharmaceuticals; Roche; Scienion; Sequenom; Siemens Healthcare; Takara Bio; Targeted Diagnostics & Therapeutics; Tosoh; Veridex; Wako Pure Chemicals; Wallac; Zila
Appendixes: Appendix I: Major Companies Developing or Marketing Tumor Marker Reagents and Instruments; Appendix II: Major Universities and Research Centers Developing Tumor Marker Detection Technologies and Applications; Appendix III: Assumed Currency Exchange Rates
List of Tables: Tumor Marker Classification; Major Companies Developing or Marketing ACTH Tests; Major Companies Developing or Marketing AFP Tests; Major Companies Developing or Marketing Beta-2 Microglobulin Tests; Major Companies Developing or Marketing CA 15-3/27.29 Tests; Major Companies Developing or Marketing CA 19-9 Tests; Major Companies Developing or Marketing CA 125 Tests; Major Companies Developing or Marketing Calcitonin Tests; Major Companies Developing or Marketing CEA Tests; Major Companies Developing or Marketing Estrogen Receptor Tests; Major Companies Developing or Marketing Progesterone Receptor Tests; Major Companies Developing or Marketing Ferritin Tests; Major Companies Developing or Marketing Gastrin Tests; Major Companies Developing or Marketing HCG Tests; Major Companies Developing or Marketing Insulin Tests; Major Companies Developing or Marketing NSE Tests; Major Companies Developing or Marketing Occult Blood Tests; Major Companies Developing or Marketing PAP Smear/HPV Tests; Major Companies Developing or Marketing PAP Tests; Major Companies Developing or Marketing PSA Tests; Major Companies Developing or Marketing Lymphocyte Subclassification Tests; Biochemical Markers Potential Applications In Cancer Diagnosis; Oncogenes Potential Applications In Cancer Diagnosis; Major Companies Developing or Marketing Oncogene Tests; Growth Factors Potential Applications In Cancer Diagnosis; Colony Stimulating Factors Potential Applications in Cancer Diagnosis; Lymphokines Potential Applications In Cancer Diagnosis; Immunohistochemical Stains Potential Applications in Cancer Diagnosis; Executive Summary Table: France, Total Tumor Marker Test Volume and Sales Forecast by Market Segment; France, Estimated Cancer Death Rates Per 100,000 Population; France, Laboratories Performing Tumor Marker Tests by Market Segment; France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size; France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume; France, Total Tumor Marker Volume Forecast by Market Segment; France, All Market Segments Major Tumor Marker Test Volume Forecast; France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test; France, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast; France, Total Tumor Marker Sales Forecast By Market Segment; France, All Market Segments Major Tumor Marker Sales Forecast by Test; France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test; France, Commercial/Private Laboratories Tumor Marker Market Forecast by Test; France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment; France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment; France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment; France, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market; France, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment; France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment; France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment; France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment; France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment; France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment; France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment; France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment; France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment; France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment; France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment; France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment; France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment; France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment; France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment; France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment; France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment; France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment; France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment; France, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment; France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment; France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment; France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment; France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment; France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment; France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment; France, Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment; France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment; France, Total Tumor Marker Sales By Major Suppliers; France, AFP Testing Market Diagnostics Sales by Major Supplier; France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier; France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier; France, CA 125 Testing Market Diagnostics Sales by Major Supplier; France, CEA Testing Market Diagnostics Sales by Major Supplier; France, NSE Testing Market Diagnostics Sales by Major Supplier; France, PAP Testing Market Diagnostics Sales by Major Supplier; France, PSA Testing Market Diagnostics Sales by Major Supplier; France, Tumor Marker Testing Instrumentation Major Systems Estimated Placements and Installed Base by Supplier and Model; Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment; Germany, Estimated Cancer Death Rates Per 100,000 Population; Germany, Laboratories Performing Tumor Marker Tests by Market Segment; Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size; Germany, Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Volume; Germany, Total Tumor Marker Test Volume Forecast by Market Segment; Germany, All Market Segments, Major Tumor Marker Test Volume Forecast; Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Assay; Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast; Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast; Germany, Total Tumor Marker Sales Forecast by Market Segment; Germany, All Market Segments Major Tumor Marker Sales Forecast by Assay; Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test; Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test; Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test; Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment; Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Calcitonin Test Volume and Diagnostic Sales Forecast by Market Segment; Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment; Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment; Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Mar Segment; Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment; Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment; Germany, Total Tumor Marker Sales By Major Supplier; Germany, AFP Testing Market Diagnostics Sales by Major Supplier; Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier; Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier; Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier; Germany, CEA Testing Market Diagnostics Sales by Major Supplier; Germany, PSA Testing Market Diagnostics Sales by Major Supplier; Germany, Tumor Marker Testing Instrumentation Major Systems; Estimated Placements and Installed Base By Supplier and Model; Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Estimated Cancer Death Rates Per 100,000 Population; Italy, Laboratories Performing Tumor Marker Tests by Market Segment; Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size; Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume; Italy, Total Tumor Marker Test Volume Forecast by Market Segment; Italy, All Market Segments Major Tumor Marker Test Volume Forecast; Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast; Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast; Italy, Total Tumor Marker Market Forecast by Market Segment; Italy, All Market Segments Major Tumor Marker Sales Forecast by Test; Italy, Hospital Laboratories Major Tumor Marker Forecast by Test; Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test; Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment; Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment; Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment; Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, S-100 Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment; Italy, Total Tumor Markers Sales by Major Supplier; Italy, AFP Testing Market Diagnostics Sales by Major Supplier; Italy, CEA Testing Market Diagnostics Sales by Major Supplier; Italy, PSA Testing Market Diagnostics Sales by Major Supplier; Italy, Tumor Marker Testing Instrumentation Major Non-Isotopic Systems Estimated Installed Base by Supplier and Model; Executive Summary Table: Japan, Total Tumor Marker Test Volume and Sales Forecast by Market Segment; Japan, Estimated Cancer Death Rates Per 100,000 Population; Japan, Laboratories Performing Tumor Marker Tests by Market Segment; Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size; Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Volume; Japan, Total Tumor Marker Test Volume Forecast by Market Segment; Japan, All Market Segments Major Tumor Marker Test Volume Forecast; Japan, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Assay; Japan, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast; Japan, Total Tumor Marker Sales Forecast by Market Segment; Japan, All Market Segments Major Tumor Marker Sales Forecast by Test; Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test; Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test; Japan, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, AFP Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, CEA Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment; Japan, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, HCG Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, NSE Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, PAP Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, PSA Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, TDT Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, TPA, Test Volume and Diagnostics Sales Forecast by Market Segment; Japan, Total Tumor Marker Sales by Major Supplier; Japan, AFP Testing Market Diagnostics Sales by Major Supplier; Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier; Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier; Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier; Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier; Japan, CEA Testing Market Diagnostics Sales by Major Supplier; Japan, NSE Testing Market Diagnostics Sales by Major Supplier; Japan, PAP Testing Market Diagnostics Sales by Major Supplier; Japan, PSA Testing Market Diagnostics Sales by Major Supplier; Japan, Tumor Marker Testing Instrumentation, Major System; Estimated Placements and Installed Base By Supplier and Model; Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment; Spain, Estimated Cancer Death Rates Per 100,000 Population; Spain, Laboratories Performing Tumor Marker Tests by Market Segment; Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size; Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume; Spain, Total Tumor Marker Test Volume Forecast by Market Segment; Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast; Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test; Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast; Spain, Total Tumor Marker Sales Forecast by Market Segment; Spain, All Market Segments Major Tumor Marker Sales Forecast by Test; Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test; Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test; Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecast by Market Segment; Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, S-100 Protein Test Volume And Diagnostics Sales Forecast by Market Segment; Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment; Spain, Total Tumor Marker Sales by Major Supplier; Spain, AFP Testing Market Diagnostics Sales by Major Supplier; Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier; Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier; Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier; Spain, CEA Testing Market Diagnostics Sales by Major Supplier; Spain, PSA Testing Market Diagnostics Sales by Major Supplier; Spain, Tumor Marker Testing Instrumentation Major Systems Estimated Placements and Installed Base by Supplier and Model; Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment; U.K., Estimated Cancer Death Rates Per 100,000 Population; U.K., Laboratories Performing Tumor Marker Tests by Market Segment; U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size; U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume; U.K., Total Tumor Marker Testing Volume Forecast by Market Segment; U.K., All Market Segments Major Tumor Marker Test Volume Forecast; U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Assay; U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast; U.K., Total Tumor Marker Sales Forecast by Market Segment; U.K., All Market Segments Major Tumor Marker Sales Forecast by Test; U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test; U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test; U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by MarketSegment; U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by MarketSegment; U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment; U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment; U.K., Total Tumor Marker Sales and Market Shares Forecast; U.K., CEA Testing Market Diagnostics Sales by Major Supplier; U.K., PSA Testing Market Diagnostics Sales by Major Supplier; U.K., Tumor Marker Testing Instrumentation Major Systems Estimated Placements and Installed Base By Supplier and Model; Executive Summary Table: U.S., Total Tumor Marker Test Volume and Sales Forecast by Market Segment; U.S., Estimated New Cancer Cases and Deaths; U.S., Estimated Cancer Death Rates Per 100,000 Population; U.S., Laboratories Performing Tumor Marker Tests by Market Segment; U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size; U.S., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume; U.S., Physician Office Laboratories Performing Tumor Marker Tests by Practice Size; U.S., Total Tumor Marker Test Volume Forecast by Market Segment; U.S., All Market Segments Major Tumor Marker Test Volume Forecast; U.S., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test; U.S., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast; U.S., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast; U.S., Cancer Clinics Major Tumor Marker Test Volume Forecast by Assay; U.S., Total Tumor Marker Sales Forecast by Market Segment; U.S., All Market Segment Major Tumor Marker Sales Forecast by Test; U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test; U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test; U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test; U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test; U.S., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., AFP Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., CEA Test Volume and Diagnostics Sales by Market Segment; U.S., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Colon-specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., HCG Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Interferons Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., NSE Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., PAP Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., PSA Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., TDT Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., TPA Test Volume and Diagnostics Sales Forecast by Market Segment; U.S., Total Tumor Marker Sales By Major Supplier; U.S., AFP Testing Market Diagnostics Sales by Major Supplier; U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier; U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier; U.S., CEA Testing Market Diagnostics Sales by Major Supplier; U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier; U.S., HCG Testing Market Diagnostics Sales by Major Supplier; U.S., Insulin Testing Market Diagnostics Sales by Major Supplier; U.S., PAP Testing Market Diagnostics Sales by Major Supplier; U.S., PSA Testing Market Diagnostics Sales by Major Supplier; U.S., Tumor Marker Testing Instrumentation Major Systems Estimated Placements and Installed Base by Supplier and Model

Research assistance

We can help you find what you need. Call us or write us:

US: 800.298.5699

Int'l: +1.240.747.3093

Need help in your search?

Related Markets

General In Vitro Diagnostics Reports

Share this report

Email a colleague

Other tasks

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!